The linkage of individuals with obesity and COVID‐19 is controversial and lacks systematic
reviews. After a systematic search of the Chinese and English language literature on COVID …

It has been more than three years since the first emergence of coronavirus disease 2019
(COVID-19) and millions of lives have been taken to date. Like most pandemics caused by …

COVID-19, the disease induced by the recently emerged severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has imposed an unpredictable burden on the world. Drug …

For the initial phase of pandemic of coronavirus disease 2019 (COVID-19), repurposing
drugs that in vitro inhibit severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) …

Background At present, the entire world is in a war against COVID-19 pandemic which has
gradually led us toward a more compromised “new normal” life. SARS-CoV-2, the …

The current coronavirus pandemic (COVID-19), caused by SARS-CoV-2, has had
devastating effects on the global health and economic system. The cellular and molecular …

The COVID-19 pandemic has emerged as an unprecedented global healthcare emergency
and has devastated the global economy. The SARS-CoV-2 virus replicates in the host cells …

Favipiravir has antiviral activity against influenza, West Nile virus, and yellow fever virus and
against flaviviruses. The objective of this pilot study was to compare three arms: favipiravir; …

Favipiravir is a broad-spectrum inhibitor of viral RNA polymerase. It is currently used as a
possible treatment for coronavirus disease 2019 (COVID-19). Pre-clinical or clinical trials of …

Introducción: La COVID-19 es una pandemia causada por el Coronavirus 2 del Síndrome
Respiratorio Agudo Severo (SARS-CoV-2); no existe hasta el momento tratamiento …